Skip to main content

Share story

AI Science

C5R reports AI-run research facility and launches lab benchmark

C5R Built a Research Lab Run by AI in 12 Weeks. The SciUniverse Benchmark Shows Why That Matters. Image: Primary
C5R says it built Facility-0, a research facility where AI models design experiments, operate equipment and interpret results across biology, chemistry and materials science. The company also released SciUniverse, a benchmark that tests whether models can turn scientific goals into results using the facility or its digital twin. C5R says it connected more than 40 instruments through custom adapters and software. Models can inspect inventory, write experimental procedures and revise their plans after reviewing measurements; some equipment instructions are passed to people. In the company's early tests, models made physical-lab mistakes including contaminating DNA and pipetting frozen samples.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from glitchwire.com and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.